cbdMD (YCBD) Liabilities and Shareholders Equity (2016 - 2026)

cbdMD has reported Liabilities and Shareholders Equity for 10 years, with the latest figure at $11.8 million in Q4 2025.

• Quarterly Liabilities and Shareholders Equity rose 2.07% year-over-year to $11.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $43.0 million (down 14.81% YoY) and the FY2025 annual result came in at $10.4 million, down 1.53% from the prior year.
• Liabilities and Shareholders Equity improved to $11.8 million in Q4 2025 per YCBD's latest filing, from $10.4 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $124.9 million in Q3 2021 and troughed at $9.9 million in Q2 2025.
• A 5-year average of $43.9 million and a median of $24.6 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2021 and 2022: Liabilities and Shareholders Equity advanced 12.67% in 2021, then slumped 67.34% in 2022.
• Over 5 years, Liabilities and Shareholders Equity stood at $99.3 million in 2021, then sank by 64.03% to $35.7 million in 2022, then plunged by 57.75% to $15.1 million in 2023, then declined by 23.53% to $11.5 million in 2024, then rose by 2.07% to $11.8 million in 2025.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $11.8 million, $10.4 million, and $9.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.